Time filter

Source Type

PubMed | Hangzhou First Peoples Hospital Hangzhou, Zhejiang Academy of Medical science Hangzhou and University of California at Los Angeles
Type: Journal Article | Journal: International journal of clinical and experimental pathology | Year: 2014

Glyoxalase 1 (Glo1) gene aberrations is associated with tumorigenesis and progression in numerous cancers. In this study, we explored the role of Glo1 genetic amplification and expression in Chinese patients with hepatocellular carcinoma (HCC), and Glo1 genetic amplification as potential therapeutic target for HCC. We used fluorescence in situ hybridization (FISH) analysis and qRT-PCR to examine Glo1 genetic aberrations and Glo1 mRNA expression in paired tumor samples obtained from HCC patients. Glo1 genetic amplification was identified in a subset of HCC patient (6%, 3/50), and up-regulation of Glo1 expression was found in 48% (24/50) of tumor tissues compared with adjacent non-tumorous tissues. Statistic analysis showed that Glo1-upregulation significantly correlated with high serum level of alpha-fetoprotein (AFP). Interfering Glo1 expression with shRNA knocking-down led to significant inhibition of cell growth and induced apoptosis in primarily cultured HCC cells carrying genetic amplified Glo1 gene, while no inhibitory effects on cell proliferation were observed in HCC cells with normal copies of Glo1 gene. Glo1 knockdown also inhibited tumor growth and induced apoptosis in xenograft tumors established from primarily cultured HCC cells with Glo1 gene amplification. In addition, Glo1 knocking-down with shRNA interfering caused cellular accumulation of methylglyoxal, a Glo1 cytotoxic substrate. Our data suggested Glo1 pathway activation is required for cell proliferation and cell survival of HCC cells carrying Glo1 genetic amplification. Intervention of Glo1 activation could be a potential therapeutic option for patients with HCC carrying Glo1 gene amplification.

PubMed | Hangzhou First Peoples Hospital Hangzhou and Zhejiang Chinese Medical University
Type: | Journal: Frontiers in microbiology | Year: 2015

To investigate the in vitro and in vivo antibacterial activities of tigecycline and other 13 common antimicrobial agents, alone or in combination, against multi-drug resistant Acinetobacter baumannii.An in vitro susceptibility test of 101 A. baumannii was used to detect minimal inhibitory concentrations (MICs). A mouse lung infection model of multi-drug resistant A. baumannii, established by the ultrasonic atomization method, was used to define in vivo antimicrobial activities.Multi-drug resistant A. baumannii showed high sensitivity to tigecycline (98% inhibition), polymyxin B (78.2% inhibition), and minocycline (74.2% inhibition). However, the use of these antimicrobial agents in combination with other antimicrobial agents produced synergistic or additive effects. In vivo data showed that white blood cell (WBC) counts in drug combination groups C (minocycline + amikacin) and D (minocycline + rifampicin) were significantly higher than in groups A (tigecycline) and B (polymyxin B) (P < 0.05), after administration of the drugs 24 h post-infection. Lung tissue inflammation gradually increased in the model group during the first 24 h after ultrasonic atomization infection; vasodilation, congestion with hemorrhage were observed 48 h post infection. After 3 days of anti-infective therapy in groups A, B, C, and D, lung tissue inflammation in each group gradually recovered with clear structures. The mortality rates in drug combination groups(groups C and D) were much lower than in groups A and B.The combination of minocycline with either rifampicin or amikacin is more effective against multi-drug resistant A. baumannii than single-agent tigecycline or polymyxin B. In addition, the mouse lung infection by ultrasonic atomization is a suitable model for drug screening and analysis of infection mechanism.

Xu H.,Zhejiang University | Li W.,Zhejiang University | Gao L.,Hangzhou First Peoples Hospital Hangzhou | Fu H.,Zhejiang University
International Medical Journal | Year: 2014

Objective: The purpose of this study was to investigate the potential association of interleukin-13 (IL-13) gene polymorphism C-1055T (rs1800925) with the susceptibility to Henoch-Schonlein Purpura (HSP) in a Chinese childhood population. Materials and Methods: Ninety-eight children with HSP and 99 healthy children as control were included in the study. A single nucleotide polymorphism C-1055T in IL-13 promoter gene was determined using TaqMan polymerase chain reaction method. Chi-square analysis was used to examine any differences of the C-1055T polymorphism in IL-13 between the HSP cases and controls. Results: No allelic or genotypic differences between the HSP patients and controls were found (P = 0.983 and 0.851, respectively). This was also the case when HSP patients were stratified by the clinical manifestations. However, we found significant difference in serum C3 levels between patients with CC genotype and non-CC genotype (P = 0.025). Conclusion: Our results suggest that the C-1055T polymorphism of the IL-13 gene may not be associated with the susceptibility to HSP in a Chinese childhood population. Allelic variation at IL-13 gene -1055 locus had no effect on serum levels of immunoglobulin and complement in patients with HSP except for C3. © 2014 Japan Health Sciences University & Japan International Cultural Exchange Foundation.

PubMed | Hangzhou First Peoples Hospital Hangzhou
Type: Journal Article | Journal: International journal of clinical and experimental pathology | Year: 2015

The aim of this study was to investigate association between expressions of multidrug resistance protein (MRP) and topoisomerase 2 alpha expression in non-small cell lung cancer (TOP2A) and brain metastasis operatively. The expression of MRP and TOP2A were performed using immunohistochemistry (IHC) staining, and the results were analyzed in correlation with clinicopathological data. A total of 286 NSCLC patients who underwent curative surgery between 2007 and 2013 were enrolled in this study. Positive expression of MRP and TOP2A were 62.2% and 37.8%. MRP positive expression in NSCLC was significantly correlated with tumor cell differentiation (P=0.028). TOP2A expression was significantly associated with patients smoking status, tumor histological type (P<0.05). The positive MRP group had significantly inferior survival rates for 2-year BMFS than did the negative MRP group (79.0% vs. 93.4%, P=0.003) by the Kaplan-Meier method and a log-rank test. Similarly, the positive TOP2A expression was inversely correlated with 2-year BMFS (84.2% vs. 93.4%, P=0.030). Multivariate analysis showed that gender, MRP expression and TOP2A expression were independent prognostic factors for BMFS (P<0.05). Positive expressions of MRP and TOP2A in the tumor tissue are associated with increased risk of developing brain metastases in NSCLC.

PubMed | Hangzhou First Peoples Hospital Hangzhou
Type: Case Reports | Journal: International journal of clinical and experimental pathology | Year: 2013

Synovial sarcoma is an uncommon, aggressive malignant tumor of the soft tissues primarily involving the extremities of young adults. Head and neck synovial sarcoma is rare, and its diagnosis and therapy are still challenging.We report a case of a young patient with synovial sarcoma, clinically masquerading as cystic mass of the neck and malignant second branchial cleft cyst. The pathological diagnosis of the sarcoma was confirmed by a multimodality diagnostic protocol, including histological, immunohistochemical and molecular genetic analysis. The patient underwent complete surgical excision followed by postoperative radiotherapy and recovered well.

Loading Hangzhou First Peoples Hospital Hangzhou collaborators
Loading Hangzhou First Peoples Hospital Hangzhou collaborators